Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Tempus Logo
Tempus Growth Score
73
CB Rank
95
Heat Score
79
Tempus develops AI-enabled precision medicine technology that supports clinical decision-making and biomedical research.
Founded
obfuscation
PublicPost-IPO Debt Chicago, Illinois, United States1001-5000 www.tempus.com
Artificial Intelligence (AI)
Biotechnology
Health Care
Machine Learning
Medical
Oncology
Precision Medicine
Overview

Tempus
Total Funding
obfuscation
Growth Score
73
Heat Score
79

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score73
-13 pts
in past quarter
Heat Score 79
4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+7 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Tempus

CB Rank
95
Tempus develops AI-enabled precision medicine technology that supports clinical decision-making and biomedical research.
Founded
obfuscation
PublicPost-IPO Debt Chicago, Illinois, United States1001-5000 www.tempus.com
Artificial Intelligence (AI)
Biotechnology
Health Care
Machine Learning
Medical
Oncology
Precision Medicine

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation

Key People

Details

Legal Name Tempus Labs, Inc.
Also Known As Tempus Labs
Operating Status Active
Number of Exits 
obfuscation
Stock Symbol  NASDAQ:TEM
Company Type For Profit
Founders  Eric Lefkofsky
About the Company

Tempus aggregates and analyzes multimodal healthcare data, including molecular, clinical, and imaging information, to generate insights for physicians and life sciences organizations. Its platform includes AI models and diagnostic assays designed to assist with disease detection, treatment selection, and identification of clinical trial

opportunities. Tempus also provides data access and analytical tools that enable researchers to study real-world evidence and therapeutic outcomes.

Phone Number 800.739.4137
Hub Tags  Exited Unicorn
Predictions & Insights

Growth Insight

See this Growth Insight
Tempus is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Products & Services

Tempus One
An AI-enabled clinical assistant that provides healthcare providers and researchers with patient insights and clinical intelligence integrated into electronic health records.
Tempus xT Platform
A genomic profiling platform that performs extensive molecular profiling combining tumor and normal sequencing to identify targeted therapies and clinical trials for cancer patients.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 15
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Tempus Logo
Post-IPO Debt - Tempus
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Tempus Logo
Post-IPO Debt - Tempus
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Tempus Logo
Post-IPO Debt - Tempus
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Tempus Logo
Post-IPO Debt - Tempus
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Tempus Logo
Post-IPO Debt - Tempus
—
obfuscation
— Post-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 15
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Tempus Logo
Post-IPO Debt - Tempus
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Tempus Logo
Post-IPO Debt - Tempus
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Tempus Logo
Post-IPO Debt - Tempus
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Tempus Logo
Post-IPO Debt - Tempus
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Tempus Logo
Post-IPO Debt - Tempus
—
obfuscation
— Post-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Ares Management Logo
Ares Management
Yes
Post-IPO Debt - Tempus Logo
Post-IPO Debt - Tempus
—
Ares Management Logo
Ares Management
Yes
Post-IPO Debt - Tempus Logo
Post-IPO Debt - Tempus
—
Ares Management Logo
Ares Management
Yes
Post-IPO Debt - Tempus Logo
Post-IPO Debt - Tempus
—
Ares Management Logo
Ares Management
Yes
Post-IPO Debt - Tempus Logo
Post-IPO Debt - Tempus
—
Ares Management Logo
Ares Management
Yes
Post-IPO Debt - Tempus Logo
Post-IPO Debt - Tempus
—

Investments

Number of Investments 5
Number of Exits 
obfuscation
Number of Acquisitions 8
See investment data for this company, with details on deal size, industry, stage, and more.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Personalis Logo
Personalis
Yes
Post-IPO Equity - Personalis Logo
Post-IPO Equity - Personalis
obfuscation
obfuscation
Personalis Logo
Personalis
Yes
Post-IPO Equity - Personalis Logo
Post-IPO Equity - Personalis
obfuscation
obfuscation
Personalis Logo
Personalis
Yes
Post-IPO Equity - Personalis Logo
Post-IPO Equity - Personalis
obfuscation
obfuscation
Personalis Logo
Personalis
Yes
Post-IPO Equity - Personalis Logo
Post-IPO Equity - Personalis
obfuscation
obfuscation
Personalis Logo
Personalis
Yes
Post-IPO Equity - Personalis Logo
Post-IPO Equity - Personalis
obfuscation

Investment Breakdown

Number of Investments 5
Number of Exits 
obfuscation
Number of Acquisitions 8
See investment data for this company, with details on deal size, industry, stage, and more.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Personalis Logo
Personalis
Yes
Post-IPO Equity - Personalis Logo
Post-IPO Equity - Personalis
obfuscation
obfuscation
Personalis Logo
Personalis
Yes
Post-IPO Equity - Personalis Logo
Post-IPO Equity - Personalis
obfuscation
obfuscation
Personalis Logo
Personalis
Yes
Post-IPO Equity - Personalis Logo
Post-IPO Equity - Personalis
obfuscation
obfuscation
Personalis Logo
Personalis
Yes
Post-IPO Equity - Personalis Logo
Post-IPO Equity - Personalis
obfuscation
obfuscation
Personalis Logo
Personalis
Yes
Post-IPO Equity - Personalis Logo
Post-IPO Equity - Personalis
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 1001-5000 Employee Profiles 32 Board Members and Advisors 3 Contacts 545

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 25, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 25, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 25, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 25, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

91,449
17.58%
 in past month

IT Spend

$273MThis year, Tempus is projected to spend $273M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
AWS Security Logo
AWS Security
100
Organizational Development Logo
Organizational Development
100
Breach and Attack Simulation Logo
Breach and Attack Simulation
100

Actively Used Products

31Tempus uses 31 technology products and services including HTML5, Adobe Flash, and  DigiCert, according to G2 Stack.

Active Website Tech Count

56Tempus is actively using 56 technologies for its website, according to BuiltWith. These include DNSSEC, SPF, and  Cloudflare CDN.

Total IP

1Tempus has 1 registered trademark in the 'Scientific and electric apparatus and instruments' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Tempus's headquarters? Tempus is located in Chicago, Illinois, United States.Who invested in Tempus? Tempus has 10 investors including Ares Management and  Ares Management.When was the last funding round for Tempus? Tempus closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are Tempus's competitors? Alternatives and possible competitors to Tempus may include Grail, Caris Life Sciences, and  Artera.How much funding has Tempus raised to date? Tempus has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(6ec160d 1)
|